19-1783186-G-A
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_138813.4(ATP8B3):c.3745C>T(p.Arg1249Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000669 in 1,613,150 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000068 ( 1 hom. )
Consequence
ATP8B3
NM_138813.4 missense
NM_138813.4 missense
Scores
5
11
2
Clinical Significance
Conservation
PhyloP100: 6.40
Publications
3 publications found
Genes affected
ATP8B3 (HGNC:13535): (ATPase phospholipid transporting 8B3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to the other. This gene encodes member 3 of phospholipid-transporting ATPase 8B; other members of this protein family are located on chromosomes 1, 15 and 18. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_138813.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP8B3 | MANE Select | c.3745C>T | p.Arg1249Cys | missense | Exon 29 of 29 | NP_620168.1 | O60423-2 | ||
| ATP8B3 | c.3634C>T | p.Arg1212Cys | missense | Exon 29 of 29 | NP_001171473.1 | O60423-3 | |||
| ATP8B3 | n.4128C>T | non_coding_transcript_exon | Exon 29 of 29 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP8B3 | TSL:1 MANE Select | c.3745C>T | p.Arg1249Cys | missense | Exon 29 of 29 | ENSP00000311336.6 | O60423-2 | ||
| ATP8B3 | TSL:1 | c.3634C>T | p.Arg1212Cys | missense | Exon 29 of 29 | ENSP00000437115.1 | O60423-3 | ||
| ATP8B3 | TSL:2 | n.*3628C>T | non_coding_transcript_exon | Exon 29 of 29 | ENSP00000444334.1 | F5GZM8 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151966Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
151966
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000646 AC: 16AN: 247518 AF XY: 0.0000446 show subpopulations
GnomAD2 exomes
AF:
AC:
16
AN:
247518
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461184Hom.: 1 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 726790 show subpopulations
GnomAD4 exome
AF:
AC:
100
AN:
1461184
Hom.:
Cov.:
31
AF XY:
AC XY:
50
AN XY:
726790
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33478
American (AMR)
AF:
AC:
4
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26118
East Asian (EAS)
AF:
AC:
1
AN:
39696
South Asian (SAS)
AF:
AC:
1
AN:
86168
European-Finnish (FIN)
AF:
AC:
0
AN:
53234
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
90
AN:
1111700
Other (OTH)
AF:
AC:
2
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000526 AC: 8AN: 151966Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74200 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
151966
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74200
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41374
American (AMR)
AF:
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
5
AN:
67960
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of MoRF binding (P = 0.0068)
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.